missing translation for 'onlineSavingsMsg'
Learn More

enQuireBio™ Recombinant Zika Envelope Domain-3 Protein

A cDNA sequence encoding the Zika Envelope Domain-3 was constructed and used to recombinantly synthesize the protein.

222.00€ - 943.00€

Specifications

Name Zika Envelope Domain-3 Protein
Regulatory Status Research Use Only
Endotoxin Concentration Not Determined. Testing recommended prior to use in cell culture and can be performed upon request.
Product Type Recombinant Protein
Cross Reactivity Zika
View More Specs

Products 3
Product Code Brand Quantity Price Quantity & Availability  
Product Code Brand Quantity Price Quantity & Availability  
15925369
View Documents
enQuireBio™
QP13998-100ug
100 μg
222.00€
100µg
Please to purchase this item. Need a web account? Register with us today!
15945369
View Documents
enQuireBio™
QP13998-500ug
500 μg
631.00€
500µg
Please to purchase this item. Need a web account? Register with us today!
15935369
View Documents
enQuireBio™
QP13998-1mg
1 mg
943.00€
1mg
Please to purchase this item. Need a web account? Register with us today!
Description

Description

Specifications

Specifications

Zika Envelope Domain-3 Protein
Not Determined. Testing recommended prior to use in cell culture and can be performed upon request.
Zika
His
Greater than 95.0% as determined by SDS-PAGE.
Research Use Only
Recombinant Protein
E. coli
Lyophilized from 1 mg/ml in 20mM sodium carbonate pH 10.
Videos
SDS
Documents

Documents

Product Certifications
Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Thank You! Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.